Pulmatrix, Inc. (PULM)

NASDAQ: PULM · Real-Time Price · USD

1.310

-0.010 (-0.76%)

Jun 3, 2026, 11:34 AM EDT - Market open

Pulmatrix Earnings Call Transcripts

Fiscal Year 2024

M&A Announcement
The merger will create a Nasdaq-listed biotech with a strong cash position, focused on advancing Cullgen's targeted protein degrader and DAC pipeline. Pulmatrix stockholders will retain a small stake and potential asset sale proceeds, while Cullgen's technology and collaborations drive future growth.

Read full transcript →

Slides

Powered by